Cargando…

In Vitro Study of Novel Collagenase (XIAFLEX®) on Dupuytren's Disease Fibroblasts Displays Unique Drug Related Properties

Dupuytren's disease (DD) is a benign, fibroproliferative disease of the palmar fascia, with excessive extracellular matrix (ECM) deposition and over-production of cytokines and growth factors, resulting in digital fixed flexion contractures limiting hand function and patient quality of life. Su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Syed, Farhatullah, Thomas, Alexis N., Singh, Subir, Kolluru, Venkatesh, Emeigh Hart, Susan G., Bayat, Ardeshir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286458/ https://www.ncbi.nlm.nih.gov/pubmed/22384021 http://dx.doi.org/10.1371/journal.pone.0031430

Ejemplares similares

The emerging role of Clostridium histolyticum collagenase in the treatment of Dupuytren disease
por: Thomas, Alexis, et al.
Publicado: (2010)

Lateral herniation during treatment with collagenase Clostridium histolyticum (Xiaflex) for Peyronie’s disease
por: Gannon, Margaret K., et al.
Publicado: (2021)

Safety of Xiaflex® (Collagenase Clostridium histolyticum) Treatment for Adult Anterior Urethral Stricture Disease
por: Wiegand, Lucas R, et al.
Publicado: (2023)

Site-Specific Keloid Fibroblasts Alter the Behaviour of Normal Skin and Normal Scar Fibroblasts through Paracrine Signalling
por: Ashcroft, Kevin J., et al.
Publicado: (2013)

Isolated and Spontaneous Correction of Proximal Interphalangeal Joint Contractures in Dupuytren’s Disease: An Exploratory Analysis of the Efficacy and Safety of Collagenase Clostridium histolyticum
por: Hayton, Michael J., et al.
Publicado: (2013)

AB009. Xiaflex as a treatment for Peyronie’s disease
por: McMahon, Chris G.
Publicado: (2015)

Potent Dual Inhibitors of TORC1 and TORC2 Complexes (KU-0063794 and KU-0068650) Demonstrate In Vitro and Ex Vivo Anti-Keloid Scar Activity
por: Syed, Farhatullah, et al.
Publicado: (2013)

Safety and tolerability of collagenase Clostridium histolyticum and fasciectomy for Dupuytren’s contracture
por: Peimer, C. A., et al.
Publicado: (2015)

Delayed vascular complication after collagenase injection for Dupuytren disease
por: Nordenskjöld, Jesper, et al.
Publicado: (2023)

Dupuytren's: a systems biology disease
por: Rehman, Samrina, et al.
Publicado: (2011)

Late Complications of Clinical Clostridium Histolyticum Collagenase Use in Dupuytren's Disease
por: Rozen, Warren M., et al.
Publicado: (2012)

Cost-Effectiveness and Patient Outcomes of Injectable Collagenase to Treat Dupuytren’s Contracture
por: Sahemey, Rajpreet S, et al.
Publicado: (2021)

Botulinum toxin as an adjunct for severe Dupuytren’s contracture treated with collagenase injections
por: Denkler, Keith A., et al.
Publicado: (2022)

Multiple concurrent collagenase clostridium histolyticum injections to dupuytren’s cords: an exploratory study
por: Coleman, Stephen, et al.
Publicado: (2012)

Retraction: Late Complications of Clinical Clostridium Histolyticum Collagenase Use in Dupuytren's Disease
por: Rozen, Warren M., et al.
Publicado: (2012)

Collagenase Clostridium Histolyticum Injection for Dupuytren Contracture: 2-Year Follow-up
por: Nayar, Suresh K., et al.
Publicado: (2019)

Needle Fasciotomy or Collagenase Injection in the Treatment of Dupuytren’s Contracture: A Retrospective Study
por: Abdelrahman, Islam, et al.
Publicado: (2020)

Comparative Effectiveness of Needle Aponeurotomy and Collagenase Injection for Dupuytren’s Contracture: A Multicenter Study
por: Zhou, Chao, et al.
Publicado: (2017)

Vascular Complication after Collagenase Injection and Manipulation for Dupuytren’s Contracture: A Case Report
por: Kawano, Yusuke, et al.
Publicado: (2019)

Acute Pain Intensity After Collagenase Clostridium histolyticum Injection in Patients With Dupuytren Contracture
por: Noto, Kimitoshi, et al.
Publicado: (2019)

Long-Term Outcomes of Collagenase Clostridium Histolyticum Injection for Palmar Dupuytren’s Deformity Correction
por: Kasture, Sarang, et al.
Publicado: (2021)

Return-to-Function Following Treatment of Dupuytren Contracture With Collagenase Clostridium Histolyticum Versus Fasciectomy
por: Divino, Victoria M., et al.
Publicado: (2020)

Real-world Medicare Healthcare Costs of Patients with Dupuytren’s Contracture Treated with Collagenase or Fasciectomy
por: Zah, Vladimir, et al.
Publicado: (2022)

111. A Long-term Comparison of Collagenase versus Fasciectomy in the Treatment of Dupuytren’s Contracture
por: Steppe, Cyrus S., et al.
Publicado: (2023)

First Identification of Resident and Circulating Fibrocytes in Dupuytren’s Disease Shown to Be Inhibited by Serum Amyloid P and Xiapex
por: Iqbal, Syed Amir, et al.
Publicado: (2014)

Efficacy of collagenase in patients who did and did not have previous hand surgery for Dupuytren's contracture
por: Bainbridge, Chris, et al.
Publicado: (2012)

Costs for collagenase injections compared with fasciectomy in the treatment of Dupuytren's contracture: a retrospective cohort study
por: Atroshi, Isam, et al.
Publicado: (2014)

Collagenase Dupuytren Contracture: Achieving Single Treatment Success with a Hand Therapist-Based Protocol
por: Malafa, Menyoli M., et al.
Publicado: (2016)

Phalangeal Fracture During Attempted Dupuytrens Release Following Clostridial Collagenase Injection: Case Report
por: Lewallen, Laura W, et al.
Publicado: (2017)

Efficacy and safety of collagenase clostridium histolyticum for Dupuytren disease nodules: a randomized controlled trial
por: Costas, Bronier, et al.
Publicado: (2017)

Collagenase Management of Multicord Dupuytren’s Disease under Intravenous Sedation: A Prospective Cohort Study
por: Wiseman, Jeremy, et al.
Publicado: (2019)

Hand therapy or not following collagenase treatment for Dupuytren’s contracture? Protocol for a randomised controlled trial
por: Aglen, Terese, et al.
Publicado: (2019)

Prospective observation of Clostridium histolyticum collagenase for the treatment of Dupuytren’s disease in 788 patients: the Austrian register
por: Rohit, Arora, et al.
Publicado: (2019)

Collagenase injections for Dupuytren disease: 3-year treatment outcomes and predictors of recurrence in 89 hands
por: Nordenskjöld, Jesper, et al.
Publicado: (2019)

Clostridium Histolyticum Collagenase Underdosed for Multicord Injection in Dupuytren’s Disease: A Retrospective Cohort Study
por: Boriani, Filippo, et al.
Publicado: (2022)

Dupuytren Disease: A Retrospective Cohort Study Comparing Collagenase Injection and Percutaneous Needle Fasciotomy
por: Mehdiyev, Turkhan, et al.
Publicado: (2022)

D3. Time from Collagenase Injection to Manipulation Does Not Affect Outcomes in Dupuytren’s Disease
por: Bingham, Elijah G., et al.
Publicado: (2023)

Understanding Dupuytren's Disease Using Systems Biology: A Move Away from Reductionism
por: Rehman, Samrina, et al.
Publicado: (2012)

Collagenase injections for Dupuytren's disease: prospective cohort study assessing 2-year treatment effect durability
por: Lauritzson, Anna, et al.
Publicado: (2017)

Collagenase Clostridium histolyticum Injection Therapy Improves Health-related Quality of Life in Patients with Dupuytren’s Disease
por: Kuboi, Takuro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8b1af5kiniqo2r0t5tdgk1320e